(Q37878480)

24 August 2017

1 reference

title

New frontiers in meningococcal vaccines (English)

1 reference

24 August 2017

2

Kathrin U Jansen

1 reference

24 August 2017

Annaliesa S Anderson

1

1 reference

24 August 2017

Joseph Eiden

series ordinal

3

1 reference

24 August 2017

publication date

1 May 2011

1 reference

Expert Review of Vaccines

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

617-634

1 reference

24 August 2017

cites work

Meningococcal disease

1 reference

Pathophysiology of meningococcal meningitis and septicaemia

21 January 2018

1 reference

Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.

21 January 2018

1 reference

Pathogenic neisseriae: surface modulation, pathogenesis and infection control

21 January 2018

1 reference

Global epidemiology of meningococcal disease.

21 January 2018

1 reference

Invasive meningococcal disease in adolescents and young adults

21 January 2018

1 reference

Prospects for vaccine prevention of meningococcal infection

21 January 2018

1 reference

Conquering the meningococcus

21 January 2018

1 reference

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution

21 January 2018

1 reference

Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa

21 January 2018

1 reference

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

21 January 2018

1 reference

Meningococcal carriage and disease--population biology and evolution

21 January 2018

1 reference

Meningococcal carriage in the African meningitis belt

21 January 2018

1 reference

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

Neisseria meningitidis: an overview of the carriage state

21 January 2018

1 reference

Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America

21 January 2018

1 reference

Advances in the development of vaccines against Neisseria meningitidis

21 January 2018

1 reference

Serogroup W135 meningococcal disease in Hajj pilgrims.

21 January 2018

1 reference

Immunization to protect the US Armed Forces: heritage, current practice, and prospects

21 January 2018

1 reference

Chapter 28: a history of bacterial meningitis

21 January 2018

1 reference

Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.

21 January 2018

1 reference

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.

21 January 2018

1 reference

Meningococcal C conjugate vaccine: the experience in England and Wales

21 January 2018

1 reference

Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C

21 January 2018

1 reference

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

21 January 2018

1 reference

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa

21 January 2018

1 reference

The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.

21 January 2018

1 reference

A review of vaccine research and development: meningococcal disease

21 January 2018

1 reference

Thymus-independent and thymus-dependent responses to polysaccharide antigens

21 January 2018

1 reference

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

21 January 2018

1 reference

Neisseria meningitidis serogroup A vaccines: an overview

21 January 2018

1 reference

Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination

21 January 2018

1 reference

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease

21 January 2018

1 reference

Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway

21 January 2018

1 reference

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

21 January 2018

1 reference

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vacc

21 January 2018

1 reference

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

21 January 2018

1 reference

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease

21 January 2018

1 reference

A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana

21 January 2018

1 reference

"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

21 January 2018

1 reference

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine

21 January 2018

1 reference

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

21 January 2018

1 reference

21 January 2018

1 reference

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.

21 January 2018

1 reference

Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine

21 January 2018

1 reference

Meningococcal PorA/C1, a channel that combines high conductance and high selectivity

21 January 2018

1 reference

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines.

21 January 2018

1 reference

Meningococcal surrogates of protection--serum bactericidal antibody activity

21 January 2018

1 reference

Scale-up for bulk production of vaccine against meningococcal disease

21 January 2018

1 reference

Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

21 January 2018

1 reference

Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06.

21 January 2018

1 reference

Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles

21 January 2018

1 reference

Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis

21 January 2018

1 reference

Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response

21 January 2018

1 reference

Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits

21 January 2018

1 reference

Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults

21 January 2018

1 reference

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

21 January 2018

1 reference

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

21 January 2018

1 reference

Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine

21 January 2018

1 reference

Distribution of transferrin binding protein B gene (tbpB) variants among Neisseria species

21 January 2018

1 reference

Role of transferrin receptor from a Neisseria meningitidis tbpB isotype II strain in human transferrin binding and virulence

21 January 2018

1 reference

Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

21 January 2018

1 reference

Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component

21 January 2018

1 reference

Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms

21 January 2018

1 reference

Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates

21 January 2018

1 reference

Cloning and expression in Escherichia coli of opc, the gene for an unusual class 5 outer membrane protein from Neisseria meningitidis (meningococci/surface antigen)

21 January 2018

1 reference

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

21 January 2018

1 reference

Recombinant Opc meningococcal protein, folded in vitro, elicits bactericidal antibodies after immunization.

21 January 2018

1 reference

Neisseria meningitidis Opc invasin binds to the cytoskeletal protein alpha-actinin

21 January 2018

1 reference

Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis.

21 January 2018

1 reference

Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci

21 January 2018

1 reference

An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.

21 January 2018

1 reference

Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells.

21 January 2018

1 reference

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

Human immunity to the meningococcus. I. The role of humoral antibodies

21 January 2018

1 reference

Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci

21 January 2018

1 reference

Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine

21 January 2018

1 reference

NadA diversity and carriage in Neisseria meningitidis

21 January 2018

1 reference

Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales

21 January 2018

1 reference

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

21 January 2018

1 reference

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

21 January 2018

1 reference

The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement

21 January 2018

1 reference

Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications

21 January 2018

1 reference

Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide.

21 January 2018

1 reference

Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage.

21 January 2018

1 reference

Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates

21 January 2018

1 reference

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

21 January 2018

1 reference

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.

21 January 2018

1 reference

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents

21 January 2018

1 reference

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

21 January 2018

1 reference

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

21 January 2018

1 reference

Lack of Association between Group B Meningococcal Disease and Autoimmune Disease

21 January 2018

1 reference

Genetic Analysis of Meningococci Carried by Children and Young Adults

21 January 2018

1 reference

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults

21 January 2018

1 reference

Lack of Immunity in University Students before an Outbreak of Serogroup C Meningococcal Infection

21 January 2018

1 reference

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.50

1 reference

24 August 2017

1 reference